ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS)


$0.24
+0.0073 ( +3.21% ) 876.7K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$0.24

Previous close


$0.23

Volume


876.7K

Market cap


$5.49M

Day range


$0.21 - $0.24

52 week range


$0.14 - $1.66

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 59 Aug 07, 2023
4 Insider transactions 1 Jul 19, 2023
4 Insider transactions 1 Jul 06, 2023

Latest News